findmyKOL
Clinical trialNCT06069570RecruitingPhase 1Interventional

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

SponsorKiromic BioPharma Inc.Enrollment48Bone Metastases From Solid TumorsCarcinoma, Non-Small-Cell Lung Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a clinical trial studying intravenous infusions of allogeneic gamma delta T cells after receiving low dose radiotherapy in participants with locally advanced or metastatic non-small cell lung cancer or solid tumors with bone metastases to evaluate the safety and efficacy of combining immunotherapy with radiation therapy.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • the University of Arizona Cancer Center

    Tucson, Arizona, United States

    Ricklie Julian, MD
    Not, yet, recruiting
  • Beverly Hills Cancer Center

    Beverly Hills, California, United States

    Afshin Gabayan, MD
    Recruiting
  • Upmc Hillman Cancer Center

    Pittsburgh, Pennsylvania, United States

    Jason Luke, MD
    Recruiting
  • Texas Oncology - Tyler

    Tyler, Texas, United States

    Donald Richards, MD, PhD
    Recruiting
  • Virginia Oncology Associates

    Norfolk, Virginia, United States

    Gary Simmons, DO, MSHA
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

KB-GDT-01
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Nov 2023
Primary completion
31 Oct 2025
Completion
31 Oct 2026
Last update posted
5 Mar 2025
Registered enrollment
48
Registry id
NCT06069570
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.